NIH-funded research R01 grant

CATSystem: a digital tool to boost cervical cancer screening and follow-up in Kenya

Official title: Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya

Funded at University of Kansas Medical Center · NIH-11535336 · Data updated 2026-11-12

A digital tracking system helps doctors and patients in Kenya improve cervical cancer screening, treatment referrals, and follow-up, especially for women living with HIV.

More Cervical Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startAugust 15, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$239,951
NIH project number3R01CA278617-04S1
Project IDNIH-11535336 on NIH RePORTER

Who could benefit from this research

Could help

Women in Kenya who are eligible for cervical cancer screening, especially those living with HIV, and who may be referred for treatment.

Less likely to help

Women without access to the participating health facilities or those without cervical cancer risk factors may not directly benefit.

What this research studies

This project tests a web-based CATSystem that uses algorithms to prompt guideline-concordant screening and ensure patients don’t fall through cracks between screening and treatment. It builds on a prior pilot in a Kenyan hospital and aims to rigorously evaluate whether the system increases onsite treatment and referrals for women with positive screens. The study focuses on low-resource settings and aims to reduce the delays and losses to follow-up that lead to worse outcomes. It involves collaboration with providers and patients to refine the tool for real-world use and sustainability.

Why it matters

Potential benefit: If successful, CATSystem could lead to higher screening rates, quicker referrals, and better retention in care for cervical cancer in Kenya.

How similar studies have gone: Previous pilots showed 2.5 to 5-fold improvements in onsite treatment and referrals, suggesting potential success.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Kessler, Sarah Finocchario — University of Kansas Medical Center
  • Study coordinator: Kessler, Sarah Finocchario

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.